Schindellegi, Switzerland

Fabio Montrasio

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations by Fabio Montrasio: A Pioneer in Antibody Development

Introduction

Fabio Montrasio, an esteemed inventor based in Schindellegi, Switzerland, has made significant contributions to the field of biotechnology with a remarkable portfolio of ten patents. His work focuses primarily on the development of human-derived antibodies for therapeutic and diagnostic purposes, showcasing his commitment to innovation in medical science.

Latest Patents

Among his latest accomplishments are two notable patents. The first involves a human-derived anti-(poly-GA) dipeptide repeat (DPR) antibody. This patent presents novel dipeptide repeat specific antibodies capable of binding to C9orf72 poly-glycine-alanine DPRs. The applications of these antibodies extend to pharmaceutical and diagnostic compositions aimed at DPR protein-targeted immunotherapy, making a considerable impact in the field.

The second patent focuses on human anti-SOD1 antibodies. This invention encompasses novel specific antibodies for copper-zinc superoxide dismutase (SOD1) and related fragments, derivatives, and variants. These antibodies can be utilized in pharmaceutical and diagnostic compositions for SOD1 targeted immunotherapy and diagnostics, marking a significant advancement in the treatment of neurodegenerative diseases.

Career Highlights

Throughout his career, Fabio Montrasio has worked with prominent organizations that have enriched his professional experience. Notably, he has been a part of Neurimmune Holding AG and Biogen International Neuroscience GmbH, where he has leveraged his expertise in antibody development to push the boundaries of medical innovation.

Collaborations

Fabio's collaborations with esteemed colleagues, such as Jan Grimm and Roger Nitsch, have played a vital role in his journey as an inventor. These partnerships have facilitated the exchange of ideas and knowledge, reinforcing the dynamic nature of scientific research and development that leads to successful innovations.

Conclusion

Fabio Montrasio stands out as a pioneering inventor in biotechnology, with a strong focus on antibody development. His patents demonstrate a profound understanding of medical needs and innovative solutions aimed at improving patient outcomes. With a strong career anchored by collaboration and significant contributions to the field, his work is bound to leave a lasting legacy in the world of pharmaceuticals and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…